Lee Ho-Su, Yang Suk-Kyun, Soh Jae Seung, Lee Seohyun, Bae Jung Ho, Lee Hyo Jeong, Park Sang Hyoung, Yang Dong-Hoon, Kim Kyung-Jo, Ye Byong Duk, Byeon Jeong-Sik, Myung Seung-Jae, Yoon Yong Sik, Yu Chang Sik, Kim Jin-Ho
*Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; †Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; and ‡Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Inflamm Bowel Dis. 2015 Aug;21(8):1825-31. doi: 10.1097/MIB.0000000000000447.
No previous studies have evaluated the long-term outcomes of acute severe ulcerative colitis (ASUC) in non-Caucasian populations. The purposes of this study were to evaluate the short- and long-term outcomes of Korean patients with ASUC.
We retrospectively analyzed 99 Korean patients with ASUC who satisfied the criteria given by Truelove and Witts between 1999 and 2005. The short-term outcome parameter was the colectomy rate during index hospitalization, and the long-term outcome parameters were the rates of colectomy and rehospitalization after discharge from index hospitalization.
During index hospitalization, 16 of 99 patients (16.2%) underwent colectomy: 6 of 71 responders (8.5%) to intravenous steroids on day 3 versus 10 of 28 nonresponders (35.7%), as assessed using the Oxford index (P = 0.002). Among 83 patients who avoided colectomy during index hospitalization, 13 patients (15.7%) underwent colectomy during the median follow-up period of 10.6 years. The cumulative probability of colectomy tended to be lower in complete responders on day 7 of intravenous steroid therapy (CR7) than in others: 3.7% versus 13.9% at 5 years and 7.6% versus 18.2% at 10 years (P = 0.100). The cumulative probability of rehospitalization was significantly lower in CR7 than in other patients: 20.5% versus 37.5% at 5 years and 31.4% versus 48.2% at 10 years (P = 0.043).
Assessing the degree of response to intravenous steroids helps predict the short- and long-term outcomes in patients with ASUC. Korean patients with ASUC may have better clinical courses than Caucasians, as indicated by the lower colectomy rate.
此前尚无研究评估非白种人群中急性重症溃疡性结肠炎(ASUC)的长期预后。本研究的目的是评估韩国ASUC患者的短期和长期预后。
我们回顾性分析了1999年至2005年间99例符合Truelove和Witts标准的韩国ASUC患者。短期预后参数是首次住院期间的结肠切除术率,长期预后参数是首次住院出院后的结肠切除术率和再次住院率。
在首次住院期间,99例患者中有16例(16.2%)接受了结肠切除术:根据牛津指数评估,71例第3天对静脉注射类固醇有反应者中有6例(8.5%),而28例无反应者中有10例(35.7%)(P = 0.002)。在首次住院期间避免行结肠切除术的83例患者中,13例(15.7%)在中位随访期10.6年期间接受了结肠切除术。静脉注射类固醇治疗第7天完全缓解者(CR7)的结肠切除术累积概率倾向于低于其他患者:5年时为3.7% 对13.9%,10年时为7.6% 对18.2%(P = 0.100)。CR7患者的再次住院累积概率显著低于其他患者:5年时为20.5% 对37.5%,10年时为31.4% 对48.2%(P = 0.043)。
评估对静脉注射类固醇的反应程度有助于预测ASUC患者的短期和长期预后。结肠切除术率较低表明,韩国ASUC患者的临床病程可能比白种人更好。